Akanda (AKAN) Change in Account Payables (2020 - 2025)
Akanda (AKAN) recorded quarterly Change in Account Payables of $2.2 million in Q2 2025, down 26.08% quarter-over-quarter from $3.0 million in Q4 2024, and down 41.38% on a YoY basis from $3.8 million in Q2 2024.
Akanda (AKAN) Change in Account Payables (2020 - 2025) Analysis & Trends
Akanda's Change in Account Payables history runs 6 years deep, the most recent figure standing at $2.2 million for Q2 2025.
- In Q2 2025, Change in Account Payables fell 41.38% year-over-year to $2.2 million; the TTM figure through Jun 2025 stood at $2.2 million (down 41.38% YoY), while the FY2024 annual figure was $3.0 million, down 50.41% from the prior year.
- Change in Account Payables was $2.2 million for Q2 2025 at Akanda, down from $3.0 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $8.5 million in Q2 2023 to a low of $680328.0 in Q4 2021.
- Historically, Change in Account Payables has averaged $4.5 million across 5 years, with a median of $4.1 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Change in Account Payables soared 949.47% in 2022, then slumped 55.55% in 2024.
- A 5-year view of Change in Account Payables shows it stood at $680328.0 in 2021, then jumped by 949.47% to $7.1 million in 2022, then dropped by 15.76% to $6.0 million in 2023, then slumped by 50.41% to $3.0 million in 2024, then slipped by 26.08% to $2.2 million in 2025.
- The last three Change in Account Payables figures came in at $2.2 million (Q2 2025), $3.0 million (Q4 2024), and $3.8 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | Akanda | 826.99 Mn | 824.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Dec 31, 2024 | 2.98 Mn |
| Dec 31, 2024 | 2.98 Mn |
| Jun 30, 2024 | 3.76 Mn |
| Jun 30, 2024 | 3.76 Mn |
| Dec 31, 2023 | 6.01 Mn |
| Dec 31, 2023 | 6.01 Mn |
| Jun 30, 2023 | 8.46 Mn |
| Jun 30, 2023 | 8.46 Mn |
| Dec 31, 2022 | 7.14 Mn |
| Dec 31, 2022 | 7.14 Mn |
| Jun 30, 2022 | 4.49 Mn |
| Jun 30, 2022 | 4.49 Mn |
| Dec 31, 2021 | 680,328.00 |
| Dec 31, 2021 | 680,328.00 |
| Dec 31, 2020 | 183,895.00 |
| Dec 31, 2020 | 183,895.00 |